Aptose Biosciences Inc. (NASDAQ:APTO) dropped 15% in a month after the company announced that it would report its financial results and offer a corporate update for the quarter ending June 30, 2021, on August 3, 2021. Recently, the company released corporate highlights from the EHA 2021 virtual congress. The event focused current Luxeptinib clinical status. …